SPHERA FUNDS MANAGEMENT LTD. - 17 Jan 2025 SCHEDULE 13G Report for Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK)

Filing manager: SPHERA FUNDS MANAGEMENT LTD.
Reporting owner: Sphera Funds Management Ltd.
Security: Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share
Symbol: OTLK
Shares outstanding: 32,903,724 shares
Disclosed shares: 1,714,284 shares
Ownership percentage: 5.2%
Form type: SCHEDULE 13G
Filing time: 03 Mar 2025, 15:58:38 UTC
Event date: 17 Jan 2025
Next filing: 10 Apr 2025
SEC filing: View on sec.gov

Key filing fact

SPHERA FUNDS MANAGEMENT LTD. disclosed 5.2% ownership in Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK) on 17 Jan 2025.

Key facts

SPHERA FUNDS MANAGEMENT LTD. filed SCHEDULE 13G for Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK).
Disclosed ownership: 5.2%.
Date of event: 17 Jan 2025.

This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
You can verify ownership claims directly against the original SEC filing.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Sphera Funds Management Ltd.	5.2%	1,714,284	1,714,284	/s/ Adi Hanetz	Adi Hanetz / General Counsel
Sphera Global Healthcare GP Ltd.	5.2%	1,714,284	1,714,284	/s/ Adi Hanetz	Adi Hanetz / General Counsel
Sphera Global Healthcare Management LP	5.2%	1,714,284	1,714,284	/s/ Adi Hanetz	Adi Hanetz / General Counsel

CIK / CUSIP context first

Broader feeds